Recombinant human endostatin (Star Lake Bioscience Co Inc Zhaoqing)

重组人血管内皮抑制素（肇庆星湖生物）

Report date: 2025/06/26 14:26:34

Base Information

Drug NameRecombinant human endostatin (Star Lake Bioscience Co Inc Zhaoqing)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionNucleolin inhibitorsIntegrin alpha-5/beta-1 antagonistsVascular endothelial growth factor receptor 1 antagonists +[4] 
TargetsIntegrin alpha-5/beta-1Vascular endothelial growth factor receptorGelatinases +[4] 
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesStar Lake Bioscience Co Inc Zhaoqing Guangdong
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesStar Lake Bioscience Co Inc Zhaoqing Guangdong
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A